Prior Auth Required

18010 - 2 Kato GJ, Piel FB, Reid CD, et al. Sickle cell disease. Nat Rev Dis Primers. 2018;4: Oct 2023

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Service2 Kato GJ, Piel FB, Reid CD, et al. Sickle cell disease. Nat Rev Dis Primers. 2018;4: Oct 2023
Procedure / Service Description

Accessed - 1 Hassell KL. Population Estimates of Sickle Cell Disease in the U.S. American Journal of Preventive Oct 2023 Medicine. 2010;38(4):S512-S521. 2 Kato GJ, Piel FB, Reid CD, et al. Sickle cell disease. Nat Rev Dis Primers. 2018;4:18010 Oct 2023 3 A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease. ClinicalTrials.gov identifier: Oct 2023 NCT03745287. Updated October 31, 2024. https://clinicaltrials.gov/study/NCT03745287

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.